When did Neuronetics report Q4 2024 earnings?

Neuronetics (STIM) reported Q4 2024 earnings on March 4, 2025 before market open.

What were Neuronetics's Q4 2024 revenue and EPS?

Neuronetics reported revenue of $22.5M and eps of $-0.33 for Q4 2024.

Did Neuronetics beat estimates in Q4 2024?

Revenue missed the consensus estimate of $28.8M by $6.3M. EPS missed the consensus estimate of $-0.26 by $0.07.

Where can I find Neuronetics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001558370-25-003833) directly on SEC EDGAR. The filing index links above go to sec.gov.

Neuronetics STIM Q4 2024 Annual earnings

Reported March 4, 2025 · Before market open

Revenue$22.5MMiss by $6.3M

EPS-$0.33Miss by $0.07

Revenue estimate$28.8M

EPS estimate-$0.26

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$40.2M

EPS estimate-$0.11

Financials

Q4 2024

Income statement

See full

Revenue$22.5M+10.7%

Gross profit$14.9M-5.6%

Operating income-$11.5M-159%

Net income-$12.7M-135%

EPS (diluted)-$0.34-88.9%

Balance sheet

See full

Cash & equivalents$18.5M-69.1%

Total debt$82.6M+32.3%

Total equity$27.7M-19.0%

Total assets$140.9M+21.6%

Cash flow

See full

Operating cash flow-$8.6M—

CapEx$89.0K-89.9%

Free cash flow-$8.7M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$89.6M+6.4%

Enterprise value$153.77M+76.7%

P/S1.2×0.0×

Profitability

See full

Gross margin72.3%-0.1pp

Operating margin-46.2%+3.9pp

Net margin-58.4%+35.7pp

FCF margin-43.3%-5.1pp

Returns & leverage

See full

Return on equity-141.2%-1,192pp

Debt / equity3×+1.2×

Current ratio1.9×-2.9×

Segments

By product

See full

Treatment Sessions$13.1M-13.1%

Neuro Star Advanced Therapy System$4.2M-8.9%

Clinic Revenue$1.1M—

Service$1.1M—

By segment

See full

Medical Device$18.0M+1.2%

Clinical Services$1.1M—

By geography

See full

Non Us$850.0K+92.3%

Versus estimates

Revenue

Q1 2026$34.5MBeat by $286.0K Q4 2025$41.8MBeat by $1.1M Q3 2025$37.3MMiss by $549.0K Q2 2025$38.1MBeat by $262.0K Q1 2025$32.0MMiss by $4.6M

Q4 2024$22.5MMiss by $6.3M

Diluted EPS

Q1 2026-$0.16Beat by $0.01 Q4 2025-$0.10Beat by $0.02 Q3 2025-$0.13Miss by $0.01 Q2 2025-$0.15Miss by $0.07 Q1 2025-$0.21Miss by $0.08

Q4 2024-$0.33Miss by $0.07

Ask the moment Neuronetics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Neuronetics report Q4 2024 earnings?: Neuronetics (STIM) reported Q4 2024 earnings on March 4, 2025 before market open.
What were Neuronetics's Q4 2024 revenue and EPS?: Neuronetics reported revenue of $22.5M and eps of $-0.33 for Q4 2024.
Did Neuronetics beat estimates in Q4 2024?: Revenue missed the consensus estimate of $28.8M by $6.3M. EPS missed the consensus estimate of $-0.26 by $0.07.
Where can I find Neuronetics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-003833) directly on SEC EDGAR. The filing index links above go to sec.gov.